# Memantine

## Witgen 10mg

##### 

| TAH Drug Code      | [OWIT1](https://www.tahsda.org.tw/drugs/hissearch.php?drug_code=OWIT1)                                                                                                                                                                                                                                    |
|:-------------------|:----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| Indications        | Alzheimer's disease (Moderate to Severe)                                                                                                                                                                                                                                                                  |
| Dosing             | Initial, 5 mg orally once daily; titrate in 5-mg increments at intervals of at least 1 week to 10 mg/day (5 mg twice daily), 15 mg/day (5 mg and 10 mg in separate doses), and 20 mg/day (10 mg twice daily); target daily dose is 20 mg/day                                                              |
| Hepatic Impairment | Dose adjustment not necessary                                                                                                                                                                                                                                                                             |
| Renal Impairment   | Dose adjustment required                                                                                                                                                                                                                                                                                  |
| Contraindications  | Hypersensitivity to memantine hydrochloride or any other components of the product                                                                                                                                                                                                                        |
| Adverse Effects    | Common Gastrointestinal: Constipation (3% to 5% ), Diarrhea (5% ), Vomiting (2% to 3% ) Neurologic: Confusion (6% ), Dizziness (5% to 7% ), Headache (adults, 6% ; pediatrics, 8% ) Serious Neurologic: Cerebrovascular accident, Seizure (up to 0.3% ) Renal: Acute renal failure Respiratory: Pneumonia |
| Pregnancy          | Unknown                                                                                                                                                                                                                                                                                                   |
| Lactation          | Unknown                                                                                                                                                                                                                                                                                                   |

